Kyoto University

Collaborators at the Keio and Osaka Universities Present Key Non-Clinical Data with Stable/Functional-Induced Regulatory T Cells (S/F-iTregs) in Autoimmune Disease Models

Retrieved on: 
Monday, May 29, 2023
Osaka University, Kyoto, Patient, Keio University, Kyoto University, ISID, Immunoglobulin G, Vaccine, Regulatory T cell, Pemphigus

OSAKA, Japan, May 29, 2023 /PRNewswire/ -- RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting.

Key Points: 
  • OSAKA, Japan, May 29, 2023 /PRNewswire/ -- RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting.
  • Their presentation demonstrated that in a murine pemphigus model, S/F-iTregs significantly decreased clinical scores, circulating anti-Dsg3 IgG titers, and other autoimmune markers related to Pemphigus.
  • Collaborators also reported that S/F-iTregs generated from samples obtained from patients with Pemphigus also showed potent inhibition of autologous T cell proliferation in vitro.
  • Tregs play a central role in managing immune self-tolerance and depleted or dysfunctional Tregs are characteristic of many autoimmune disorders.

Collaborators at the Keio and Osaka Universities Present Key Non-Clinical Data with Stable/Functional-Induced Regulatory T Cells (S/F-iTregs) in Autoimmune Disease Models

Retrieved on: 
Monday, May 29, 2023
Osaka University, Kyoto, Patient, Keio University, Kyoto University, ISID, Immunoglobulin G, Vaccine, Regulatory T cell, Pemphigus

OSAKA, Japan, May 29, 2023 /PRNewswire/ -- RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting.

Key Points: 
  • OSAKA, Japan, May 29, 2023 /PRNewswire/ -- RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting.
  • Their presentation demonstrated that in a murine pemphigus model, S/F-iTregs significantly decreased clinical scores, circulating anti-Dsg3 IgG titers, and other autoimmune markers related to Pemphigus.
  • Collaborators also reported that S/F-iTregs generated from samples obtained from patients with Pemphigus also showed potent inhibition of autologous T cell proliferation in vitro.
  • Tregs play a central role in managing immune self-tolerance and depleted or dysfunctional Tregs are characteristic of many autoimmune disorders.

East West Bank Appoints Dr. Jason Hsu of Rayliant Global Advisors as Chief Economist

Retrieved on: 
Tuesday, May 23, 2023
Banking, Asset Management, Professional Services, Finance, Uncertainty, Partnership, University, Anderson School, Multimedia, UCLA Anderson School of Management, Kyoto University, Tsinghua University, National Chengchi University, University of California, Los Angeles, Bank, UCLA, Robert D. Arnott, National Advisory Committee on Institutional Quality and Integrity, Data science, Cryptocurrency

East West Bancorp, Inc. ("East West" or the "Company") (Nasdaq: EWBC), parent company of East West Bank , today announced the appointment of Dr. Jason Hsu , founder and Chief Investment Officer of Rayliant Global Advisors (“Rayliant”), as the Chief Economist for East West Bank.

Key Points: 
  • East West Bancorp, Inc. ("East West" or the "Company") (Nasdaq: EWBC), parent company of East West Bank , today announced the appointment of Dr. Jason Hsu , founder and Chief Investment Officer of Rayliant Global Advisors (“Rayliant”), as the Chief Economist for East West Bank.
  • View the full release here: https://www.businesswire.com/news/home/20230523006078/en/
    Rayliant founder and new East West Bank Chief Economist Dr. Jason Hsu (Photo: Business Wire)
    “Dr.
  • Hsu is a preeminent leader in the fields of finance and investment management, and we are delighted to welcome him as the Chief Economist of East West Bank,” stated Dominic Ng, Chairman and Chief Executive Officer of East West Bancorp.
  • “East West Bank and Rayliant were both founded on a shared mission of serving as the bridge between the East and West.

Mitsubishi Corporation Invests in Kyoto Fusioneering, a spin-off from Kyoto University

Retrieved on: 
Wednesday, May 17, 2023
Carbon, Deuterium, University, MC, Electricity, KF, Light, Research, Government, Tritium, Seawater, Kyoto University, Helium, CO2, Lithium, Renewable energy

Its establishment in 2019 was based on decades of fusion research and development by Kyoto University.

Key Points: 
  • Its establishment in 2019 was based on decades of fusion research and development by Kyoto University.
  • KF specializes in key components and integrated systems that are required in order to build fusion reactors and fusion power plants.
  • KF's strategic aim is to build a fusion energy supply chain by leveraging Japan's leading manufacturing capabilities.
  • (Based on the provisional translation of "Fusion Energy Innovation Strategy" adopted by Japan's Integrated Innovation Strategy Promotion Council on April 14, 2023)

Fujitsu, Kyoto University, and Chordia Therapeutics launch AI trials to discover biomarkers for new cancer drugs

Retrieved on: 
Wednesday, May 17, 2023
Probability, Drug development, Cancer, Biomarker, RNA, Patient, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto University, Fujitsu, Diagnosis, Therapy, Gene, Genome, Pharmaceutical industry, Chordia

This information will assist researchers working to discover biomarkers for patient stratification that can be used to determine the efficacy of cancer treatments that target RNA regulatory stress (5), under development by Kyoto University and Chordia since May 2018.

Key Points: 
  • This information will assist researchers working to discover biomarkers for patient stratification that can be used to determine the efficacy of cancer treatments that target RNA regulatory stress (5), under development by Kyoto University and Chordia since May 2018.
  • Through this demonstration, Fujitsu, Kyoto University, and Chordia Therapeutics aim to realize new cancer treatments personalized to individual patients' genetic characteristics, cancer symptoms and progression, ultimately improving patient outcomes and well-being.
  • A variety of biomarkers are currently used in the medical field for preventative care, diagnosis, and treatment selection of cancer.
  • In clinical trials, biomarkers make it possible for drug development researchers to focus on specific characteristics, improving the likelihood of developing successful and effective new drug candidates.

ISARA Expands Strategic Leadership, Appoints CEO and Executive Chairman

Retrieved on: 
Wednesday, May 10, 2023
United States National Security Council, United Nations Security Council, PQC, White House, Telecom, University, Doctor of Philosophy, Open Kernel Labs, Policy, Emerging, Research, Kevin Mital, Special Assistance Program (Australian education), Dartmouth College, Government, White, Critical infrastructure, Organization, Microsoft, Engineering, Kyoto University, Gen Digital, Physics, National security council, AI, Mathematics, Quantum computing, Management, Cryptocurrency

WATERLOO, ON, May 10, 2023 /PRNewswire/ -- ISARA, the leader in post-quantum cryptography (PQC) and cryptographic risk management, today announced two executive leadership appointments that will expand and support the company's strategic direction. Atsushi Yamada was named CEO and Amit Mital was named executive chairman. Both bring significant cryptographic and technological leadership experience in enterprise and government, as ISARA expands its focus to include post-quantum cryptography professional services.

Key Points: 
  • Atsushi Yamada was named CEO and Amit Mital was named executive chairman.
  • Both bring significant cryptographic and technological leadership experience in enterprise and government, as ISARA expands its focus to include post-quantum cryptography professional services.
  • "At ISARA, we pride ourselves on building a quantum-safe world," stated Atsushi Yamada, CEO of ISARA.
  • "ISARA has an excellent crypto-agile technology foundation and I look forward to taking the company to a new level and helping organizations manage their quantum-safe journeys every step of the way," said Amit Mital, executive chairman of ISARA.

Study Links "Stuck" Stem Cells to Hair Turning Gray

Retrieved on: 
Wednesday, April 19, 2023
Human, Hair, Travel, Nature, Defense, Ronald, WNT, NYU, Human hair color, Ageing, New York University Grossman School of Medicine, Research, Mount Sinai, Cell, Milwaukee, Doctor of Philosophy, National Institutes of Health, Bangladesh Technical Education Board, Icahn School of Medicine at Mount Sinai, NYU Langone Health, Protein, Cell biology, Publishing, Kyoto University, Mouse, B cell, Melanocyte, Department of Defence, Skin, Wool, Cosmetics, Dermatology, Medicine

This means that during normal hair growth, such cells continually move back and forth on the maturity axis as they transit between compartments of the developing hair follicle.

Key Points: 
  • This means that during normal hair growth, such cells continually move back and forth on the maturity axis as they transit between compartments of the developing hair follicle.
  • The researchers found that as hair ages, sheds, and then repeatedly grows back, increasing numbers of McSCs get stuck in the stem cell compartment called the hair follicle bulge.
  • "Our study adds to our basic understanding of how melanocyte stem cells work to color hair," said study lead investigator Qi Sun, PhD, a postdoctoral fellow at NYU Langone Health.
  • For example, transit-amplifying hair follicle cells never revert to their original stem cell state.

Mitsubishi Corporation: Donation for the establishment of incubation program with Kyoto University

Retrieved on: 
Thursday, April 13, 2023
University, MC, Growth, Philosophy, Climate change, Innovation, Mitsubishi Corporation, Research, Infection, Society, Kyoto University, Pharmaceutical industry

TOKYO, Apr 13, 2023 - (JCN Newswire) - Mitsubishi Corporation (MC) has decided to make a donation of 600 million yen to Kyoto University to support the establishment of a new start-up support program, which will implement the research findings of Kyoto University.

Key Points: 
  • TOKYO, Apr 13, 2023 - (JCN Newswire) - Mitsubishi Corporation (MC) has decided to make a donation of 600 million yen to Kyoto University to support the establishment of a new start-up support program, which will implement the research findings of Kyoto University.
  • Kyoto University has been conducting highly specialized research in a wide range of fields for many years.
  • In support of its philosophy, MC has decided to make a donation to the incubation program to be newly established by Office of Society-Academia Collaboration for Innovation, Kyoto University.
  • The "Kyoto University-Mitsubishi Corporation Startup Catapult" will utilize the research achievements of Kyoto University and provide financial support for research projects aiming to start businesses.

Canadian Nuclear Laboratories and Kyoto Fusioneering Partner to Accelerate the Development of Fusion Energy

Retrieved on: 
Thursday, March 30, 2023
Science, technology, engineering, and mathematics, Canadian Nuclear Laboratories Research Facilities, UNITY, Heart, Partnership, Optimism, CNL, Hydrogen, Breeding, Electricity, Chalk River Laboratories, Research, General Fusion, History, Organization, Tritium, MOU, Kyoto University, Lithium, Science

Under terms of the agreement, the organizations will work together to identify and co-develop fusion products and services, helping to accelerate the progression of fusion as a source of clean energy.

Key Points: 
  • Under terms of the agreement, the organizations will work together to identify and co-develop fusion products and services, helping to accelerate the progression of fusion as a source of clean energy.
  • “That is at the heart of this agreement with Kyoto Fusioneering, an incredibly talented and ambitious company which shares our optimism in fusion power.
  • Among the advanced technologies that Kyoto Fusioneering is developing for commercial fusion reactors is tritium fuel cycle technologies and breeding blankets for tritium production and power generation.
  • That work includes a partnership with First Light Fusion to explore tritium extraction technologies; and an MOU signed with General Fusion .

Noster Microbiome research: Fibrous fuel: Prebiotic fibers can keep the body's metabolism in check to improve gut-environment and suppress obesity

Retrieved on: 
Thursday, March 23, 2023
Tokyo University of Agriculture and Technology, Extrapyramidal system, Tissue, University of Tokyo, Cellulose, Obesity, Diet, SCFA, Diabetes, Probiotic, Digestion, Fed, Nutritional science, Blood, Metabolism, Leuconostoc mesenteroides, Kyoto University, Yogurt, Host, HFD, Mouse, EPS, Bacteria, Health, Bacillota, System, Prebiotic (nutrition), Human, Gum arabic, Dietary supplement, Leuconostoc, Verrucomicrobiota, Bacteroides, Bacteroidota

Probiotic foods such as miso and kimchi are rich in bacteria that keep the gut and body healthy.

Key Points: 
  • Probiotic foods such as miso and kimchi are rich in bacteria that keep the gut and body healthy.
  • A complementary food group known as prebiotics (mainly fibrous foods) serve as fuel for these bacteria to thrive.
  • Lactic acid bacteria, such as Leuconostoc mesenteroides (L. mesenteroides), are used in the fermentation process of fermented foods such as kimchi, sauerkraut, and pickles.
  • The researchers thus focused their study on the potential role of LmEPS as a prebiotic fiber.